Clinical Trials

Inclusion Criteria:

• Patient is 18 to 80 years of age.

• Patient has a medically confirmed diagnosis of ADPKD via COD

  • ADPKD Mayo Class: 1B-1E

  • eGFR = 30 – 90 ml/min/1.73m²

• Patient is willing and capable of providing informed consent to participate in the study and is willing to sign the consent form.

• Participants must self-report, via the online screener, either (a) not having experienced any lifetime ADPKD-related pain (Group 1: No Pain Cohort) or (b) having experienced ADPKD-related pain within the past 4 weeks/last month (Group 2: Pain Cohort)

  Patient provides consent via the ICF, including consent to be audio recorded

  Patient is physically, cognitively, and linguistically able to participate in one or two one-on-one, up to 80-minute telephone interviews in English using an internet-enabled computer or other device (such as a tablet) with screensharing / screen-viewing capabilities.

  Patient is a fluent English speaker able to read, write, and fully understand the English language.

  Patient resides in the US.

Exclusion Criteria:

• In the opinion of the site (based on the information shared), the participant has any medical condition or disorder that could compromise their ability to:

• Provide consent to participate.

• Successfully participate in a web-based interview and provide meaningful information about their experience.

• Have another chronic condition which could confound the results of this study (causes pain)

• Currently participating in a clinical trial or has participated in a clinical trial within the last 30 days at the time of recruitment.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 6/20/2025. Questions regarding updates should be directed to the study team contact.